Skip to main content
Photo of Tahir Latif, MBBS, MBA

Tahir Latif, MBBS, MBA

Professor of Clinical

Director, Infusion Services UCMC

Internal Medicine | College of Medicine

  • Bachelor's Degree: Punjab University
  • Medical Degree: Allama Iqbal Medical College
  • Internship: Cleveland Clinic Florida
  • Residency: Cleveland Clinic Florida
  • Fellowship: Cleveland Clinic Foundation
  • Master's Degree: Texas Tech University Rawls College of Business Administration
Board Certifications & Licenses

American Board of Internal Medicine (Hematology) (Certification Date: 20041103)
American Board of Internal Medicine (Medical Oncology) (Certification Date: 20041103)


Internal Medicine
Medical Oncology

Contact Information
Research Interests

Hematological Cancers, Colorectal Cancer  

Clinical Interests

Medical Oncology

Hematology and Oncology


Acute Lymphocytic Leukemia

Acute Myeloid Leukemia


Anal Cancer

Castleman Disease

Chronic Lymphocytic Leukemia

Chronic Myelogenous Leukemia

Colon Cancer



M Protein



Mantle Cell Lymphoma

Mediastinal Adenopathy

Monoclonal gammopathy

Monoclonal protein

Mycosis Fugoides

Myelodysplastic Syndrome


Myeloproliferative Disorder


Plasma Cell Disorder

Plasminogen Activator Inhibitor 1

Polycythemia vera


Rectal Cancer

Sideroblastic anemia

T-cell lymphoma



Dr. Latif is actively involved in clinical research and scholarly activities in hematologic malignancies and GI oncology, having published numerous peer-reviewed journal articles, as well as review articles in prestigious journals such as Bone Marrow Transplantation, Critical Review in Hematology Oncology, and Experimental Hematology.  

Dr. Latif currently serves as Professor of Clinical Medicine in the Division of Hematology Oncology and Director of Infusion Services, UCMC, is a practicing Hematologist and Oncologist with special interest in malignant hematology (lymphoproliferative disorders). Dr. Latif graduated from Allama Iqbal Medical College, University of the Punjab in 1996 and completed his residency and fellowship training from Cleveland Clinic Florida and Cleveland Clinic foundation respectively. He’s been in practice for over 15 years and has trained and educated many oncologists in Cincinnati Area. 

He has keen interest in improving efficiency and quality of health care with development of lean systems and has adopted several process improvement initiative at Univercity of Cincinnati since his arrival. 

Peer Reviewed Publications

Kharofa, Jordan; Mierzwa, Michelle; Olowokure, Olugbenga; Sussman, Jeffrey; Latif, Tahir; Gupta, Anumeha; Xie, Changchun; Patel, Sameer; Esslinger, Hope; Mcgill, Brian; Wolf, Eric; Ahmad, Syed A 2019. Pattern of Marginal Local Failure in a Phase II Trial of Neoadjuvant Chemotherapy and Stereotactic Body Radiation Therapy for Resectable and Borderline Resectable Pancreas Cancer. American journal of clinical oncology, 42 3, 247-252

Das, M K; Ali, M A; Latif, T; Islam, M N; Hossain, M A; Moniruzzaman, M M; Oliullah, M; Haque, S A; Gosh, A K 2018. Comparison of Serum Electrolytes Abnormality and Renal Function Status in Asphyxiated and Normal Baby in a Tertiary Level Hospital. Mymensingh medical journal : MMJ, 27 4, 723-729

Kim, Young; Stahl, Christopher C; Makramalla, Abouelmagd; Olowokure, Olugbenga O; Ristagno, Ross L; Dhar, Vikrom K; Schoech, Michael R; Chadalavada, Seetharam; Latif, Tahir; Kharofa, Jordan; Bari, Khurram; Shah, Shimul A 2017. Downstaging therapy followed by liver transplantation for hepatocellular carcinoma beyond Milan criteria. Surgery, 162 6, 1250-1258

Blanco, Victor M; Latif, Tahir; Chu, Zhengtao; Qi, Xiaoyang 2015. Imaging and Therapy of Pancreatic Cancer with Phosphatidylserine-Targeted Nanovesicles. Translational oncology, 8 3, 196-203

Ghose, Abhimanyu; Elias, Harold Kunal; Guha, Gunjan; Yellu, Mahender; Kundu, Ria; Latif, Tahir 2015. Influence of Rituximab on Central Nervous System Relapse in Diffuse Large B-Cell Lymphoma and Role of Prophylaxis--A Systematic Review of Prospective Studies. Clinical lymphoma, myeloma & leukemia, 15 8, 451-7

Jagannathan, S; Abdel-Malek, M A Y; Malek, E; Vad, N; Latif, T; Anderson, K C; Driscoll, J J 2015. Pharmacologic screens reveal metformin that suppresses GRP78-dependent autophagy to enhance the anti-myeloma effect of bortezomib. Leukemia, 29 11, 2184-91

Ghose, Abhimanyu; Kundu, Ria; Latif, Tahir 2014. Prophylactic CNS directed therapy in systemic diffuse large B cell lymphoma. Critical reviews in oncology/hematology, ,

Ghose, Abhimanyu; Yellu, Mahender; Wise-Draper, Trisha; Sharma, Divya; Qualtieri, Julianne; Latif, Tahir; Medlin, Stephen 2014. Lymphoma presenting as secondary HLH: a review with a tale of two cases. Clinical lymphoma, myeloma & leukemia, 14 6, e187-93

Haider, S; Latif, T; Hochhausler, A; Lucas, F; Abdel Karim, N 2013. Waldenstrom's Macroglobulinemia and Peripheral Neuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes with a Bleeding Diathesis and Rash. Case reports in oncological medicine, 2013 , 890864

Latif, Tahir; Chauhan, Nabeel; Khan, Rashid; Moran, Andrea; Usmani, Saad Z 2012. Thalidomide and its analogues in the treatment of Multiple Myeloma. Experimental hematology & oncology, 1 1, 27

Raza, Azra; Cruz, Raymond; Latif, Tahir; Mukherjee, Siddhartha; Galili, Naomi 2010. The biology of myelodysplastic syndromes: unity despite heterogeneity. Hematology reports, 2 1, e4

Latif, Tahir; Hussein, Mohamad A 2005. Advances in multiple myeloma and spine disease. Clinical lymphoma & myeloma, 6 3, 228-33

Latif, Tahir; Wood, Laura; Connell, Cindy; Smith, David C; Vaughn, David; Lebwohl, David; Peereboom, David 2005. Phase II study of oral bis (aceto) ammine dichloro (cyclohexamine) platinum (IV) (JM-216, BMS-182751) given daily x 5 in hormone refractory prostate cancer (HRPC). Investigational new drugs, 23 1, 79-84

Latif, T; Hsi, E D; Rybicki, L A; Adelstein, D J 2004. Is there a role for folate determinations in current clinical practice in the USA? Clinical and laboratory haematology, 26 6, 379-83

Latif, T; Pohlman, B; Kalaycio, M; Sobecks, R; Hsi, E D; Andresen, S; Bolwell, B J 2003. Syngeneic graft-versus-host disease: a report of two cases and literature review. Bone marrow transplantation, 32 5, 535-9

Latif, T; Steiman, D M; Gagaoudakis, P 2001. Massive right atrial thrombosis due to Hickman catheter requiring open heart surgery--a case report. Angiology, 52 6, 425-8

Abstract Publications

J. Shah, T. Latif, P. Elson, E. Hsi, M. Kalaycio 2005. A retrospective study comparing demographics, cytogentic findings, and prognosis in acute myeloid leukemia with and without leukemia cutis Proc Am Soc Clin Oncol , 23 ,

T. S. Chan, T. Latif, B. Pohlman, K. Theil, P. Elson, R. Sobecks, B. Bolwell, M. Kalaycio 2004. High dose therapy (HDT) and autologous stem cell transplantation (ASCT) in diffuse large B cell lymphoma (DLBL) patients with secondary central nervous system (CNS) involvement Journal of Clinical Oncology, ASCO Annual Meeting Proceedings (Post Meeting Edition) , 22 14S-July 15 Supplement, 6658

Latif T, Bolwell B, Rybicki L, Kuczkowski E, Kalaycio M, Jarvis J, Sobecks R, Andresen Pohlman B, Maciejewski J 2003. Analysis of CD34 subsets of patients undergoing autologous stem cell transplant (ABMT) with cells mobilized by either G-CSF alone or G-CSF plus VP 16 Blood 2003, 102 11, 8b [3571]

Latif T, Elson P, Karam MA, Reed J, Tahir K, Srkalovic G, Hussein MA 2003. Incidence of renal impairment (RI) in Multiple Myeloma (MM) patients receiving combination chemotherapy and thalidomide (Thal) with bisphosphonate therapy Blood 2003, 102 11, [2545]

Latif T, Kalaycio M, Pohlman B, Sobecks R, Andresen S, Rybicki L, Kuczkowski E, Cherni K, Bernhard L, Ostendorf H, Bolwell B 2003. The prognostic significance of the day 12 and day 42 platelet count after autologous stem cell transplant (ASCT) in patients with diffuse large B cell lymphoma (DLBL) Blood 2003, 102 11, [2722]

Wlodarski M, Wu R, Magdalena P, Latif T, Lichtin A, Maciejewski JP 2003. Can seldi mass spectrometry serum proteomics be applied to improve diagnosis of ITP? Blood 2003, 102 11, [1049]

Latif T, Skelton J, Perez-Tripichio A, Woodhouse, S 2000. A lot of normal folate levels! Proceedings of ACP-ASIM Florida Chapter Annual Meeting 2000, ,

Aziz Z, Qazi S, Latif T, Akram S, Rehman A . Prevalence of anxiety and depression in cancer patients receiving chemotherapy Annals of Oncology 1998, 11 4, 143

Latif T, Elson P, Karam MA, Reed J, Tso E, Srkalovic G, Hussein MA . Liposomal doxorubicin, Vincristine, reduced frequency Dexamethsone and Thalidomide (DVd-T) for newly diagnosed Multiple Myeloma (MM) patients Proc Am Soc Clin Oncol 2003, 11 , 601a (A 2419)

Latif T, Hsi E, Rybicki L, Adelstein D . Efficacy of serum folate determination in clinical practice Blood 2002, 100 11, 8b [3482]

Latif T, Kalaycio M, Pohlman B, Sobecks R, Andresen S, Rybicki L, Brown S, Kuczkowski E, Bernhard L, Ostendorf H, Cherni K, Bolwell B . The prognostic significance of the absolute lymphocyte count (ALC) at day 12 and day 42 after autologous stem cell transplant (ASCT) in patients with diffuse large B cell lymphoma (DLBL) Blood 2003, 102 11, [5444]

Latif T, Steiman D, Gourgouh P . Massive right atrial thrombus due to hickman catheter requiring open-heart surgery Proceedings of ACP-ASIM Florida Chapter annual meeting 1999, ,